Investigational drug for osteoporosis inhibits serotonin synthesis in the gut

An investigational drug that inhibits serotonin synthesis in the gut, administered orally once daily, effectively cured osteoporosis in mice and rats reports an international team led by researchers from Columbia University Medical Center, in the Feb. 7 issue of Nature Medicine.

Related posts:

1. Investigational drug that inhibits serotonin synthesis in gut cures osteoporosis
2. Serotonin May Be a Key to Treat Osteoporosis
3. Investigational New Drug application for Uricase-PEG 20 approved